Selected Grants
TARGET-PBC A 5-year Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis
ResearchPrincipal Investigator · Awarded by Target Corporation · 2017 - 2023IM101-823 - Abatacept for treatment of recurrent or de novo autoimmune hepatitis
Clinical TrialClinical Investigator · Awarded by The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership · 2019 - 2021External Relationships
- University of Louisville Office of CME and Professional Development
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.